These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 25553296)

  • 1. Non-homologous end joining repair mechanism-mediated deletion of CHD7 gene in a patient with typical CHARGE syndrome.
    Lee SJ; Chae JH; Lee JA; Cho SI; Seo SH; Park H; Seong MW; Park SS
    Ann Lab Med; 2015 Jan; 35(1):141-5. PubMed ID: 25553296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of three novel mutations in the CHD7 gene in patients with clinical signs of typical or atypical CHARGE syndrome.
    Michelucci A; Ghirri P; Iacopetti P; Conidi ME; Fogli A; Baldinotti F; Lunardi S; Forli F; Moscuzza F; Berrettini S; Boldrini A; Simi P; Pellegrini S
    Int J Pediatr Otorhinolaryngol; 2010 Dec; 74(12):1441-4. PubMed ID: 20943277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete screening of 50 patients with CHARGE syndrome for anomalies in the CHD7 gene using a denaturing high-performance liquid chromatography-based protocol: new guidelines and a proposal for routine diagnosis.
    Bilan F; Legendre M; Charraud V; Manière B; Couet D; Gilbert-Dussardier B; Kitzis A
    J Mol Diagn; 2012 Jan; 14(1):46-55. PubMed ID: 22033296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Alu retrotransposition-mediated deletion of CHD7 in a patient with CHARGE syndrome.
    Udaka T; Okamoto N; Aramaki M; Torii C; Kosaki R; Hosokai N; Hayakawa T; Takahata N; Takahashi T; Kosaki K
    Am J Med Genet A; 2007 Apr; 143A(7):721-6. PubMed ID: 17334995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CHARGE syndrome due to deletion of region upstream of CHD7 gene START codon.
    Pisaneschi E; Sirleto P; Lepri FR; Genovese S; Dentici ML; Petrocchi S; Angioni A; Digilio MC; Dallapiccola B
    BMC Med Genet; 2015 Sep; 16():78. PubMed ID: 26334530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CHD7 mutations and CHARGE syndrome: the clinical implications of an expanding phenotype.
    Bergman JE; Janssen N; Hoefsloot LH; Jongmans MC; Hofstra RM; van Ravenswaaij-Arts CM
    J Med Genet; 2011 May; 48(5):334-42. PubMed ID: 21378379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revealing the function of a novel splice-site mutation of CHD7 in CHARGE syndrome.
    Lee B; Duz MB; Sagong B; Koparir A; Lee KY; Choi JY; Seven M; Yuksel A; Kim UK; Ozen M
    Gene; 2016 Feb; 576(2 Pt 2):776-81. PubMed ID: 26551301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of a novel CHD7 CHARGE syndrome variant by integrated omics analyses.
    Granadillo JL; Wegner DJ; Paul AJ; Willing M; Sisco K; Tedder ML; Sadikovic B; Wambach JA; Baldridge D; Cole FS;
    Am J Med Genet A; 2021 Feb; 185(2):544-548. PubMed ID: 33184947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of one novel CHD7 mutation in a patient from China with atypical CHARGE syndrome.
    Cheng J; Ma D; Wu Y; Luo C; Huang C; Hu P; Zhang J; Jiang T; Xu Z
    Gene; 2015 Oct; 571(2):298-302. PubMed ID: 26187070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for replicative mechanism in a CHD7 rearrangement in a patient with CHARGE syndrome.
    Vatta M; Niu Z; Lupski JR; Putnam P; Spoonamore KG; Fang P; Eng CM; Willis AS
    Am J Med Genet A; 2013 Dec; 161A(12):3182-6. PubMed ID: 23956205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence of CHD7 missense versus truncating mutations is higher in patients with Kallmann syndrome than in typical CHARGE patients.
    Marcos S; Sarfati J; Leroy C; Fouveaut C; Parent P; Metz C; Wolczynski S; Gérard M; Bieth E; Kurtz F; Verier-Mine O; Perrin L; Archambeaud F; Cabrol S; Rodien P; Hove H; Prescott T; Lacombe D; Christin-Maitre S; Touraine P; Hieronimus S; Dewailly D; Young J; Pugeat M; Hardelin JP; Dodé C
    J Clin Endocrinol Metab; 2014 Oct; 99(10):E2138-43. PubMed ID: 25077900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic spectrum of CHARGE syndrome based on clinical characteristics.
    Aksel Kılıçarslan Ö; Ataman E; Gürsoy S; Hazan F; Randa C; Çankaya T; Erçal D; Ülgenalp A; Giray Bozkaya Ö
    Turk J Med Sci; 2018 Oct; 48(5):911-915. PubMed ID: 30384553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular analysis of the CHD7 gene in CHARGE syndrome: identification of 22 novel mutations and evidence for a low contribution of large CHD7 deletions.
    Vuorela P; Ala-Mello S; Saloranta C; Penttinen M; Pöyhönen M; Huoponen K; Borozdin W; Bausch B; Botzenhart EM; Wilhelm C; Kääriäinen H; Kohlhase J
    Genet Med; 2007 Oct; 9(10):690-4. PubMed ID: 18073582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel CHD7 variant disrupting acceptor splice site in a patient with mild features of CHARGE syndrome: a case report.
    Siavrienė E; Petraitytė G; Mikštienė V; Rančelis T; Maldžienė Ž; Morkūnienė A; Byčkova J; Utkus A; Kučinskas V; Preikšaitienė E
    BMC Med Genet; 2019 Jul; 20(1):127. PubMed ID: 31315586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical phenotypes associated with pathogenic CHD7 variants and a proposal for broadening CHARGE syndrome clinical diagnostic criteria.
    Hale CL; Niederriter AN; Green GE; Martin DM
    Am J Med Genet A; 2016 Feb; 170A(2):344-354. PubMed ID: 26590800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CHD7 mutation spectrum in 28 Swedish patients diagnosed with CHARGE syndrome.
    Wincent J; Holmberg E; Strömland K; Soller M; Mirzaei L; Djureinovic T; Robinson K; Anderlid B; Schoumans J
    Clin Genet; 2008 Jul; 74(1):31-8. PubMed ID: 18445044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal diagnosis of CHARGE syndrome by identification of a novel CHD7 mutation in a previously unaffected family.
    Colin E; Bonneau D; Boussion F; Guichet A; Delorme B; Triau S; Gillard P; Kitzis A; Bilan F
    Prenat Diagn; 2012 Jul; 32(7):692-4. PubMed ID: 22517486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic spectrum of CHARGE syndrome in fetuses with CHD7 truncating mutations correlates with expression during human development.
    Sanlaville D; Etchevers HC; Gonzales M; Martinovic J; Clément-Ziza M; Delezoide AL; Aubry MC; Pelet A; Chemouny S; Cruaud C; Audollent S; Esculpavit C; Goudefroye G; Ozilou C; Fredouille C; Joye N; Morichon-Delvallez N; Dumez Y; Weissenbach J; Munnich A; Amiel J; Encha-Razavi F; Lyonnet S; Vekemans M; Attié-Bitach T
    J Med Genet; 2006 Mar; 43(3):211-217. PubMed ID: 16169932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 8q12.1q12.3 de novo microdeletion involving the CHD7 gene in a patient without the major features of CHARGE syndrome: case report and critical review of the literature.
    Palumbo O; Palumbo P; Stallone R; Palladino T; Zelante L; Carella M
    Gene; 2013 Jan; 513(1):209-13. PubMed ID: 23142376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exon copy number alterations of the CHD7 gene are not a major cause of CHARGE and CHARGE-like syndrome.
    Bergman JE; de Wijs I; Jongmans MC; Admiraal RJ; Hoefsloot LH; van Ravenswaaij-Arts CM
    Eur J Med Genet; 2008; 51(5):417-25. PubMed ID: 18472328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.